Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
about
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predispositionPrevalence and impact of founder mutations in hereditary breast cancer in Latin America.Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.Portuguese c.156_157insAlu BRCA2 founder mutation: gastrointestinal and tongue neoplasias may be part of the phenotype.
P2860
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
@en
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
@nl
type
label
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
@en
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
@nl
prefLabel
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
@en
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
@nl
P50
P1476
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.
@en
P2093
Susana Bizarro
P2888
P304
P356
10.1007/S10549-008-0214-Z
P407
P577
2008-10-14T00:00:00Z